story of the week
Predictors of Poor Response and Adverse Events Following Botulinum Toxin-A for Refractory Idiopathic Overactive Bladder
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Urology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Predictors of Poor Response and Adverse Events Following Botulinum Toxin-A for Refractory Idiopathic Overactive Bladder
Urology 2020 Jan 01;135(1)32-37, M Abrar, L Stroman, S Malde, E Solomon, A SahaiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.